News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,966 Results
Type
Article (982)
Company Profile (12)
Press Release (74972)
Section
Business (21309)
Career Advice (131)
Deals (8328)
Drug Development (6725)
Employer Resources (2)
FDA (1330)
Job Trends (1567)
News (38210)
Policy (2773)
Tag
Academia (88)
Allergies (2)
Alliances (5945)
ALS (9)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (3)
Approvals (1343)
Artificial intelligence (6)
Automation (2)
Bankruptcy (85)
Best Places to Work (1396)
Biosimilars (9)
Biotechnology (8)
Bladder cancer (6)
Brain cancer (2)
Breast cancer (21)
Cancer (215)
Cardiovascular disease (7)
Career advice (112)
CAR-T (8)
Cell therapy (30)
Cervical cancer (1)
Clinical research (5715)
Collaboration (60)
Compensation (25)
COVID-19 (95)
C-suite (23)
Cystic fibrosis (10)
Data (227)
Depression (3)
Diabetes (20)
Diagnostics (693)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (7521)
Employer branding (1)
Employer resources (2)
Events (10395)
Executive appointments (100)
FDA (1462)
Frontotemporal dementia (1)
Funding (88)
Gene editing (3)
Gene therapy (8)
GLP-1 (25)
Government (194)
Guidances (14)
Healthcare (1999)
Immunology and inflammation (4)
Indications (2)
Infectious disease (105)
Inflammatory bowel disease (22)
Influenza (5)
Intellectual property (11)
Interviews (23)
IPO (4863)
Job creations (209)
Job search strategy (95)
Layoffs (10)
Legal (900)
Liver cancer (3)
Lung cancer (35)
Lymphoma (10)
Manufacturing (22)
MASH (6)
Medical device (1819)
Medtech (1819)
Mergers & acquisitions (3735)
Metabolic disorders (42)
Multiple sclerosis (7)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (188)
NextGen: Class of 2025 (907)
Non-profit (163)
Obesity (17)
Opinion (2)
Ovarian cancer (8)
Pain (11)
Pancreatic cancer (21)
Parkinson's disease (21)
Partnered (3)
Patents (38)
Patient recruitment (13)
Peanut (2)
People (6601)
Pharmacy benefit managers (2)
Phase I (1768)
Phase II (2654)
Phase III (1868)
Pipeline (159)
Policy (1)
Postmarket research (147)
Preclinical (692)
Press Release (1)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (44)
Rare diseases (27)
Real estate (526)
Recruiting (1)
Regulatory (1857)
Reports (5)
Research institute (136)
Resumes & cover letters (15)
RSV (3)
Schizophrenia (10)
Series A (8)
Series B (7)
Sickle cell disease (8)
Spinal muscular atrophy (2)
Startups (496)
State (1)
Stomach cancer (1)
Supply chain (6)
Vaccines (24)
Weight loss (2)
Date
Last 7 days (98)
Last 30 days (289)
Last 365 days (3878)
2025 (1286)
2024 (4463)
2023 (5514)
2022 (6727)
2021 (7865)
2020 (7574)
2019 (5281)
2018 (4093)
2017 (3929)
2016 (3244)
2015 (4540)
2014 (3105)
2013 (2542)
2012 (2714)
2011 (2365)
2010 (2113)
Location
Africa (21)
Alabama (2)
Arizona (23)
Arkansas (1)
Asia (3741)
Australia (470)
California (758)
Canada (158)
China (31)
Colorado (21)
Connecticut (47)
Delaware (13)
Europe (5258)
Florida (152)
Georgia (23)
Idaho (7)
Illinois (59)
India (1)
Indiana (55)
Japan (12)
Kansas (19)
Kentucky (2)
Maine (35)
Maryland (106)
Massachusetts (478)
Michigan (63)
Minnesota (45)
Mississippi (2)
Missouri (11)
Montana (2)
Nebraska (3)
Nevada (27)
New Hampshire (10)
New Jersey (278)
New Mexico (2)
New York (290)
North Carolina (191)
Northern California (273)
Ohio (38)
Oregon (2)
Pennsylvania (206)
Rhode Island (3)
South America (65)
South Carolina (7)
Southern California (312)
Tennessee (24)
Texas (180)
United States (3215)
Utah (42)
Virginia (28)
Washington D.C. (1)
Washington State (56)
West Virginia (1)
Wisconsin (11)
75,966 Results for "ajinomoto aminoscience llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
May 7, 2025
·
3 min read
Press Releases
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
April 24, 2025
·
3 min read
Ajinomoto Co. Launches Silicon Valley CVC HQ to Grow U.S. Investments, Adds New Portfolios
Ajinomoto Co., Inc., the Japan-based multinational corporation covering food, healthcare and electronic materials, and built on “AminoScience,” has expanded its corporate venture capital arm with new U.S. headquarters to grow its investments in U.S. and global companies.
February 13, 2024
·
2 min read
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Ajinomoto Co., Inc. launched a new version of its StemFit™ iPSC expansion medium.
March 26, 2024
·
3 min read
Deals
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
Ajinomoto Co., Inc. and Forge Biologics, announced that they have entered into a definitive agreement by which Ajinomoto Co., will acquire Forge, a leading manufacturer of genetic medicines, in an all-cash deal for $620 million.
November 13, 2023
·
4 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Biotech Beach
Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service for both the Overall and Big Pharma respondent groups.
March 12, 2024
·
2 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
1 of 7,597
Next
